共 16 条
- [3] Utility of Molecular Testing for Subtyping of New Precursor B-Cell Neoplasm Entities (WHO-HAEM5 Classification, 2022): A Single Center Experience JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S50 - S51
- [8] Value of Comprehensive Mutational Profiling in Subtyping TLymphoblastic Leukemia/Lymphoma (T-ALL/LBL) per 2022 WHO & ICC at a Single Center JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S51 - S51